Table of Content - Drug Device Combination Products Market

Global drug device combination products are innovative solutions in the field of healthcare that integrate drugs, devices, and/or biological products. These products combine the therapeutic properties of drugs with the functionality of medical devices, resulting in safer and more effective treatments for patients. The combination of drugs and medical devices allows for targeted and precise delivery of medications, enhancing the efficacy of the treatment. For example, drug-eluting stents release medication directly at the site of a blocked artery, promoting faster healing and reducing the risk of restenosis. drug device combination products offer several advantages over traditional therapies. They can simplify treatment regimens by combining multiple therapies into a single product, reducing the burden on patients and healthcare providers. This can lead to improved patient adherence to treatment plans and better health outcomes.

Market Dynamics:

Rise in burden of chronic disorders, growing geriatric population, favorable government policies or initiatives to ensure patient safety, the outbreak of COVID-19 (pandemic), and the introduction of novel products by market players are major factors expected to drive growth of the global drug device combination product market over the forecast period.

For instance, according to the Centers for Disease Control and Prevention (CDC), 6 in 10 people in the U.S. live with at least one chronic disease, such as heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in the U.S., and they are also a leading driver of health care costs.

Moreover, in October 2020, Medtronic received the U.S. Food and Drug Administration (FDA) approval for the Abre Venous Self-Expanding Stent System. The system is indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction.

Key features of the study:

This report provides in-depth analysis of the global drug device combination product market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global drug device combination product market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include AbbVie Inc. (Allergan), Terumo Corporation, GlaxoSmithKline PLC, Novartis AG, Medtronic PLC, Abbott Laboratories, Boston Scientific Corp., W L Gore and Associates Inc., Stryker Corporation, and Becton, Dickinson and Company,
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global drug device combination product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analystsStakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug device combination product market

Detailed Segmentation:

Global Drug Device Combination Product Market, By Products:
- Drug Eluting Stents
- Transdermal Patches
- Infusion Pumps
- Drug Eluting Balloon
- Inhalers
- Other Products
Global Drug Device Combination Product Market, By Application:
- Cardiovascular
- Diabetes
- Cancer Treatment
- Respiratory Diseases
- Other Applications
Global Drug Device Combination Product Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Other End User
Global Drug Device Combination Product Market, By Region:
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East & Africa
  - GCC
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - Central Africa
  - North Africa
Company Profiles:
- AbbVie Inc. (Allergan)
- Terumo Corporation
- GlaxoSmithKline PLC
- Novartis AG
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corp.
- W L Gore and Associates Inc.
- Stryker Corporation
- Becton, Dickinson and Company

Table of Contents:

Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Market Snapshot, By Products
Market Snapshot, By Application
Market Snapshot, By End-User
Market Snapshot, By Region

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Increase in burden of chronic disorders
Product recalls and associated complications
Outbreak of COVID-19 (global pandemic)

Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario

Global Drug Device Combination Product Market– Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

Global Drug Device Combination Product Market, By Products, 2023-2030, (US$ Bn)

Introduction

Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends

Drug Eluting Stents

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Transdermal Patches

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Infusion Pumps

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Drug Eluting Balloon

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Inhalers

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Other Products

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Global Drug Device Combination Product Market, By Application, 2023-2030, (US$ Bn)

Introduction

Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends

Cardiovascular

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Diabetes

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Cancer Treatment

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Respiratory Diseases

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Other Applications

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Global Drug Device Combination Product Market, By End User, 2023-2030, (US$ Bn)

Introduction

Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends

Hospitals

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Ambulatory Surgical Centers

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Other Applications

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

Global Drug Device Combination Product Market, By region, 2023-2030, (US$ Bn)

Introduction

Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 – 2030
Segment Trends

North America

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Products Type, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 – 2030, (US$ Billion)

U.S.
Canada

Latin America

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Products Type, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 – 2030, (US$ Billion)

Brazil
Mexico
Argentina
Rest of Latin America

Europe

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Products Type, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 – 2030, (US$ Billion)

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Products Type, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 – 2030, (US$ Billion)

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Middle East

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Products Type, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018 - 2030, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 – 2030, (US$ Billion)

GCC
Israel
Rest of Middle East

Africa

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,( US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018 – 2030, (US$ Million)

South Africa
Central Africa
North Africa

Competitive Landscape

AbbVie Inc. (Allergan)

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Terumo Corporation

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

GlaxoSmithKline PLC

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Novartis AG

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Medtronic PLC

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Abbott Laboratories

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Boston Scientific Corp.

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

W L Gore and Associates Inc.

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Stryker Corporation

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Becton, Dickinson and Company

Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies

Analyst Views

Section

Research Methodology
About us

*Browse 40 market data tables and 33 figures on "Global Drug Device Combination Product Market”- forecast to 2030

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE